Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03814031 · ClinicalTrials.gov registry record
Hepatic Vein Flow During Orthotopic Liver Transplantation as Predictive Factor for Postoperative Graft Function
A clinical trial, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 97
- Enrollment target
NCT03814031 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 97 participants.
The verdict
NCT03814031 has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
Study Summary
Hepatic vein flow (HVF) assessment using transesophageal echocardiography (TEE) has a potential to predict postoperative graft function in orthotopic liver transplant (OLT). Investigators will measure HVF using TEE and assess the correlation with postoperative graft function indices such as early allograft dysfunction(EAD), prolonged INR, platelet, and total bilirubin.
Interventions
- OTHER NO internvention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2018-02-20 |
| Est. Completion | 2019-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03814031
The ClinicalTrials.gov registry entry for NCT03814031 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NO internvention is the first listed.
NCT03814031 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03814031 about?
NCT03814031 is a clinical study titled "Hepatic Vein Flow During Orthotopic Liver Transplantation as Predictive Factor for Postoperative Graft Function". Hepatic vein flow (HVF) assessment using transesophageal echocardiography (TEE) has a potential to predict postoperative graft function in orthotopic liver transplant (OLT). Investigators will measure HVF using TEE and assess the correlation with postoperative graft function indices such as early al...
What is the current status of trial NCT03814031?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2018-02-20. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03814031?
The interventions under investigation include: NO internvention (OTHER).
Who is sponsoring clinical trial NCT03814031?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.